News
US blood testing company cuts workforce by 40%
BMJ 2016; 355 doi: https://doi.org/10.1136/bmj.i5474 (Published 07 October 2016) Cite this as: BMJ 2016;355:i5474- Michael McCarthy
- Seattle
The controversial US biotechnology company Theranos, which is currently facing federal sanctions, has announced that it will close its clinical laboratories, shut its retail wellness centers, and lay off 40% of its workforce.
Theranos came under scrutiny last year when reports emerged that the company was using its technology to run only a fraction of the blood tests it conducted and was instead relying on traditional devices made by other companies to process the …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.